Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - PR Newswire
  Neurizon licenses animal health drug to Elanco for faster launch - Vietnam Investment Review - VIR
  Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts - GlobeNewswire
  Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China - The Manila Times
  Ionis and Ono announce global license agreement for sapablursen in polycythemia vera - Business Wire
  Roche enters into an exclusive collaboration ' licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity - Roche
  Vor Bio's Massive $4B Autoimmune Drug Deal Transforms Company Under New CEO Leadership - Stock Titan
  Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor - Bayer